This map shows the geographic impact of P Fender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Fender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Fender more than expected).
This network shows the impact of papers produced by P Fender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Fender. The network helps show where P Fender may publish in the future.
Co-authorship network of co-authors of P Fender
This figure shows the co-authorship network connecting the top 25 collaborators of P Fender.
A scholar is included among the top collaborators of P Fender based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with P Fender. P Fender is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Vauzelle-Kervroëdan, F, F. Javoy, Anne Forhan, P Fender, & E Eschwège. (2008). Pharmacoépidémiologie du diabète : évaluation du bon usage des antidiabétiques oraux. Diabetes & Metabolism. 26. 63–68.2 indexed citations
2.
Weill, Alain, P. Ricordeau, N Vallier, et al.. (2008). L'analyse des prestations remboursées par l'assurance maladie : matériel et méthodes. Diabetes & Metabolism. 26. 49–54.2 indexed citations
Vallier, N, et al.. (2003). Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, 2000. 34(2). 75–84.40 indexed citations
Cash, Roland, et al.. (2001). Facteurs influençant le coût du diabète du type 1 sans complication en 1994. 19(4). 243–261.2 indexed citations
14.
Ricordeau, P., Alain Weill, N Vallier, et al.. (2000). L'épidémiologie du diabète en France métropolitaine. Diabetes & Metabolism. 26. 11–24.47 indexed citations
15.
Weill, Alain, et al.. (2000). [Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998].. PubMed. 26 Suppl 6. 39–48.8 indexed citations
16.
Vauzelle-Kervroëdan, F, et al.. (2000). Le diabète de type II pris en charge à 100 % en 1994 : caractéristiques et suivi. Diabetes & Metabolism. 26. 55–62.2 indexed citations
17.
Allemand, H. & P Fender. (2000). Un programme de santé publique pour une meilleure prise en charge des malades. Diabetes & Metabolism. 26. 7–11.2 indexed citations
18.
Detournay, B., F Vauzelle-Kervroëdan, Marie‐Aline Charles, et al.. (1999). [Epidemiology, management and costs of type 2 diabetes in France in 1998].. PubMed. 25(4). 356–65.21 indexed citations
19.
Vauzelle-Kervroëdan, F, Anne Forhan, F. Javoy, P Fender, & E Eschwège. (1999). [Pharmacoepidemiology of diabetes: contribution of a survey of health insurance cases].. PubMed. 25(2). 163–71.1 indexed citations
20.
Fender, P & Gérard Bréart. (1982). [Perinatal mortality in the E.E.C. and Sweden. The demographic, political, and socio-economic factors].. PubMed. 11(3). 329–35.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.